Pancreatic Cancer Research

ResearcherUniversity of CopenhagenActive in the last 2 years

Ivana Novak

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8917-8010; OpenAlex author ID A5046179891, A5124632382. Sources: OpenAlex.

Their work

Papers
17 (first author 2, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
45
Papers, trials and grants by year

2014: 1 paper · 2015: 3 papers · 2016: 5 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 17

  1. pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/apha.70183↗
  2. Pantoprazole and riluzole target H+/K+-ATPases and pH-sensitive K+ channels in pancreatic cancer cells. Last author DOI 10.1002/ijc.35076↗
  3. Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer. Last author DOI 10.1186/s12935-024-03339-9↗
  4. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells. Last author DOI 10.3390/cells10081928↗
  5. Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreatic Cancer and Stellate Cells. Last author DOI 10.3390/cancers12030640↗
  6. The Vacuolar H+ ATPase α3 Subunit Negatively Regulates Migration and Invasion of Human Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/cells9020465↗
  7. Purinergic Signaling in Pancreas-From Physiology to Therapeutic Strategies in Pancreatic Cancer. Co-author DOI 10.3390/ijms21228781↗
  8. Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer. First author DOI 10.1002/bies.201600253↗
  9. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells. Last author DOI 10.1002/ijc.30380↗
  10. In silico analysis of the transportome in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00249-016-1171-9↗
  11. KCa3.1 (IK) modulates pancreatic cancer cell migration, invasion and proliferation: anomalous effects on TRAM-34. Last author DOI 10.1007/s00424-016-1891-9↗
  12. pH-sensitive K(+) channel TREK-1 is a novel target in pancreatic cancer. Last author DOI 10.1016/j.bbadis.2016.07.009↗
  13. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.1097/mpa.0000000000000571↗
  14. ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC). First author DOI 10.1007/s00424-014-1598-8↗
  15. Corrigendum: Acid-base transport in pancreatic cancer: Molecular mechanisms and clinical potential. Co-author DOI 10.1139/bcb-2015-0026↗
  16. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. Last author DOI 10.1186/s12943-015-0472-4↗
  17. Acid-base transport in pancreatic cancer: molecular mechanisms and clinical potential. Co-author DOI 10.1139/bcb-2014-0078↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ganga Deshar · 4 shared papers, 2020–2026 · strength 0.91
  2. Stine F. Pedersen · 8 shared papers, 2014–2026 · strength 0.75
  3. Lara Magni · 4 shared papers, 2020–2024 · strength 0.63
  4. Frauke Alves · 3 shared papers, 2016–2026 · strength 0.35
  5. Sofie Hagelund · 2 shared papers, 2020–2026 · strength 0.31
  6. Annarosa Arcangeli · 2 shared papers, 2020–2026 · strength 0.30
  7. Andrea Giannuzzo · 4 shared papers, 2014–2016 · strength 0.29
  8. Albrecht Schwab · 2 shared papers, 2017–2026 · strength 0.28
  9. Luis A. Pardo · 2 shared papers, 2017–2026 · strength 0.28
  10. Marco Tozzi · 2 shared papers, 2020–2021 · strength 0.27
  11. Stephan J. Reshkin · 2 shared papers, 2016–2026 · strength 0.25
  12. Anna Trauzold · 2 shared papers, 2016–2026 · strength 0.25
  13. Daniel Rafael Peter Sauter · 3 shared papers, 2015–2016 · strength 0.22
  14. Astrid Zedlitz Johansen · 1 shared paper, 2024 · strength 0.20
  15. Julia Sidenius Johansen · 1 shared paper, 2024 · strength 0.20
  16. Su Chii Kong · 3 shared papers, 2014–2016 · strength 0.20
  17. Pawel Swietach · 1 shared paper, 2026 · strength 0.19
  18. Verena Hofschröer · 1 shared paper, 2026 · strength 0.19
  19. Laura Mezzanotte · 1 shared paper, 2026 · strength 0.19
  20. Zoltán Pethő · 1 shared paper, 2026 · strength 0.19
  21. Tiago M. A. Carvalho · 1 shared paper, 2026 · strength 0.19
  22. Torsten Hechler · 1 shared paper, 2026 · strength 0.19
  23. Rosa Angela Cardone · 1 shared paper, 2026 · strength 0.19
  24. Julie Schnipper · 1 shared paper, 2026 · strength 0.19
  25. Wiktoria Błaszczak · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.